Canan Nebigil

Affiliations: 
Duke University, Durham, NC 
Google:
"Canan Nebigil"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Vincenzi M, Kremic A, Jouve A, et al. (2023) . Pharmacological Reviews
Demir F, Urayama K, Audebrand A, et al. (2021) Pressure Overload-Mediated Sustained PKR2 (Prokineticin-2 Receptor) Signaling in Cardiomyocytes Contributes to Cardiac Hypertrophy and Endotheliopathies. Hypertension (Dallas, Tex. : 1979). 77: 1559-1570
Gasser A, Chen YW, Audebrand A, et al. (2019) Prokineticin Receptor-1 Signaling Inhibits Dose- and Time-Dependent Anthracycline-Induced Cardiovascular Toxicity Via Myocardial and Vascular Protection. Jacc. Cardiooncology. 1: 84-102
Nebigil CG, Désaubry L. (2019) The role of GPCR signaling in cardiac Epithelial to Mesenchymal Transformation (EMT). Trends in Cardiovascular Medicine. 29: 200-204
Gasser A, Chen Y, Audebrand A, et al. (2019) Prokineticin Receptor-1 Signaling Inhibits Dose- and Time-Dependent Anthracycline-Induced Cardiovascular Toxicity Via Myocardial and Vascular Protection Jacc: Cardiooncology. 1: 84-102
Qureshi R, Kindo M, Boulberdaa M, et al. (2018) A prokineticin-driven epigenetic switch regulates human epicardial cell stemness and fate. Stem Cells (Dayton, Ohio)
Qureshi R, Kindo M, Arora H, et al. (2017) Prokineticin receptor-1-dependent paracrine and autocrine pathways control cardiac tcf21(+) fibroblast progenitor cell transformation into adipocytes and vascular cells. Scientific Reports. 7: 12804
Arora H, Boulberdaa M, Qureshi R, et al. (2016) Prokineticin receptor-1 signaling promotes Epicardial to Mesenchymal Transition during heart development. Scientific Reports. 6: 25541
Gasser A, Brogi S, Urayama K, et al. (2015) Discovery and cardioprotective effects of the first non-Peptide agonists of the G protein-coupled prokineticin receptor-1. Plos One. 10: e0121027
Désaubry L, Zhao Q, Basmadjian C, et al. (2015) P5.02Development of Novel Anticancer Agents that Target Prohibitins and the Translation Initiation Factor eIF4A Annals of Oncology. 26
See more...